• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Cholesterol Ester Storage Disease

Cholesterol Ester Storage Disease - 17 Studies Found

Completed : An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    : 2012-02-01
Completed : National Lysosomal Acid Lipase Deficiency Study
: Cholesteryl Ester Storage Disease
: 2015-02-21
Recruiting : Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study
:
  • Non-alcoholic Fatty Liver Disease
  • Cholesterol Ester Storage Disease : 2013-02-10
Recruiting : Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
:
  • Lysosomal Acid Lipase Deficiency
  • Cholesterol Ester Storage Disease : 2012-10-26
    : Other: enzyme analysis
Completed : Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
:
  • Wolman Disease
  • Cholesterol Ester Storage Disease
  • : 2013-03-13
    : Other: There are no interventions in this study.
Active, not recruiting : Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency
:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    : 2011-11-26
    :
    • Drug: SBC-102 (sebelipase alfa)

Completed : Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Patients With Lysosomal Acid Lipase Deficiency
:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    : 2011-03-01
    :
    • Drug: SBC-102 (sebelipase alfa)

Active, not recruiting : A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
:
  • Cholesterol Ester Storage Disease (CESD)
  • Lysosomal Acid Lipase
    : 2012-12-17
    :
    • Drug: SBC-102 [sebelipase alfa] (1 mg/kg)

Completed : Biomarker for Wolman Disease
:
  • Wolman Disease
  • Acid Lipase Deficiency
  • Acid Cholesteryl Est
    : 2015-03-03
Completed : Lysosomal Acid Lipase (LAL) Deficiency Registry
:
  • Lysosomal Acid Lipase Deficiency
  • Cholesterol Ester Storage Disease : 2012-06-29
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.